CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Vous n'êtes pas connecté
Cardinal Health's (CAH) fourth-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
CTLT's solid segmental results led to an encouraging fiscal fourth-quarter performance, driving up share prices in after-hours trading.
PAHC's impressive fourth-quarter fiscal 2024 results can be attributed to the Animal Health segment's robust performance.
VIRC's fiscal second-quarter results are likely to reflect a solid vertically integrated model and operating capabilities.
Adobe's fiscal third-quarter results are likely to reflect solid momentum across Creative Cloud and Document Cloud.
ORCL's fiscal first-quarter results are likely to reflect rapid adoption and progress in AI-based cloud services offering potential for future...
LTRX Q4 fiscal 2024 performance is likely to have gained from the uptake of its solutions across its Smart Cities, Automotive and Enterprise business...
LTRX Q4 fiscal 2024 performance is likely to have gained from the uptake of its solutions across its Smart Cities, Automotive and Enterprise business...
BOWL's fourth-quarter fiscal 2024 performance is likely to have benefited from strong event performance and higher league and walk-in-retail revenues.
HOFT's second-quarter fiscal 2025 results are likely to reflect softness in home furnishings demand trends, along with hiked costs and expenses.